Morgan Stanley on Rubius (RUBY) New Strategy and Restructuring: 'removes potential for near-term clinical catalyst'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Morgan Stanley on Rubius (RUBY) New Strategy and Restructuring: 'removes potential for near-term clinical catalyst'
(NASDAQ: RUBY) Delayed: 0.08 --0 (-0%)
Previous Close $0.08    52 Week High $ 
Open $1.17    52 Week Low $ 
Day High $0.08    P/E N/A 
Day Low $0.08    EPS $ 
Volume 518,325